{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:50:42Z","timestamp":1793505042147,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014824","name":"Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020582","name":"National Institute of Pharmaceutical Education and Research, Raebareli","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bmcl.2025.130327","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T13:32:59Z","timestamp":1751635979000},"page":"130327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Synthesis and evaluation of novel dihydropyrimidine\u2013oxadiazole hybrid scaffolds as anticholinesterase agents: SAR and in-silico studies"],"prefix":"10.1016","volume":"128","author":[{"given":"Ramesh","family":"Ambatwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokesh","family":"Chandrakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok K.","family":"Datusalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal L.","family":"Khatik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bmcl.2025.130327_bb0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1021\/acschemneuro.3c00588","article-title":"Discovery of quinolinone hybrids as dual inhibitors of acetylcholinesterase and A\u03b2 aggregation for Alzheimer\u2019s disease therapy","volume":"15","author":"Manzoor","year":"2024","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130327_bb0010","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/joim.13244","article-title":"Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer\u2019s disease (MCI and dementia) in primary care: a review and synthesis","volume":"290","author":"Liss","year":"2021","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130327_bb0015","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","article-title":"Alzheimer\u2019s disease: epidemiology and clinical progression","volume":"11","author":"Tahami Monfared","year":"2022","journal-title":"Neurol Ther"},{"key":"10.1016\/j.bmcl.2025.130327_bb0020","first-page":"2","article-title":"World Alzheimer Report 2020","volume":"I","author":"Fleming","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130327_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0459-7","article-title":"Prevalence and risk of progression of preclinical Alzheimer\u2019s disease stages: a systematic review and meta-analysis","volume":"11","author":"Parnetti","year":"2019","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130327_bb0030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s40291-022-00608-z","article-title":"Future prospects for epigenetics in autism spectrum disorder","volume":"26","author":"Williams","year":"2022","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.bmcl.2025.130327_bb0035","first-page":"31","article-title":"Recent advancements in the treatment of Alzheimer\u2019s disease: a multitarget-directed ligand approach","author":"Kumar","year":"2023","journal-title":"Curr Med Chem"},{"issue":"October 2023","key":"10.1016\/j.bmcl.2025.130327_bb0040","article-title":"Piperazine-2-carboxylic acid derivatives as MTDLs anti-Alzheimer agents: anticholinesterase activity, mechanistic aspect, and molecular modeling studies","volume":"142","author":"Soliman","year":"2024","journal-title":"Bioorg Chem"},{"issue":"21","key":"10.1016\/j.bmcl.2025.130327_bb0045","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1021\/acschemneuro.0c00579","article-title":"Scope of \u03b2-secretase (BACE1)-targeted therapy in Alzheimer\u2019s disease: emphasizing the flavonoid based natural scaffold for BACE1 inhibition","volume":"11","author":"Das","year":"2020","journal-title":"ACS Chem Neurosci"},{"issue":"December 2023","key":"10.1016\/j.bmcl.2025.130327_bb0050","article-title":"Design, synthesis, in vitro and in silico evaluations of new isatin-triazine- aniline hybrids as potent anti- Alzheimer multi-target directed lead compounds","volume":"147","author":"Tamaddon-Abibigloo","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2025.130327_bb0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejmech.2015.03.040","article-title":"Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer\u2019s disease","volume":"95","author":"Xie","year":"2015","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130327_bb0060","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1021\/acschemneuro.3c00653","article-title":"Design, synthesis, and biological investigation of quinazoline derivatives as multitargeting therapeutics in Alzheimer\u2019s disease therapy","volume":"15","author":"Verma","year":"2024","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130327_bb0065","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/slct.201702599","article-title":"Pyrimidine-Triazolopyrimidine and pyrimidine-pyridine hybrids as potential acetylcholinesterase inhibitors for Alzheimer\u2019s disease","volume":"3","author":"Kumar","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmcl.2025.130327_bb0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bioorg.2016.10.002","article-title":"Rational design and synthesis of dihydropyrimidine based dual binding site acetylcholinesterase inhibitors","volume":"69","author":"Ahmad","year":"2016","journal-title":"Bioorg Chem"},{"issue":"June 2018","key":"10.1016\/j.bmcl.2025.130327_bb0075","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bioorg.2018.10.035","article-title":"Design, synthesis and bioevaluation of tricyclic fused ring system as dual binding site acetylcholinesterase inhibitors","volume":"83","author":"Tanoli","year":"2019","journal-title":"Bioorg Chem"},{"issue":"2\u20133","key":"10.1016\/j.bmcl.2025.130327_bb0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ardp.200400927","article-title":"New oxadiazole derivatives showing partly antiplatelet, antithrombotic and serotonin antagonistic properties","volume":"338","author":"Bethge","year":"2005","journal-title":"Arch Pharm (Weinheim)"},{"issue":"21","key":"10.1016\/j.bmcl.2025.130327_bb0085","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1039\/b908937c","article-title":"The new era of 1,2,4-oxadiazoles","volume":"7","author":"Pace","year":"2009","journal-title":"Org Biomol Chem"},{"issue":"October 2021","key":"10.1016\/j.bmcl.2025.130327_bb0090","article-title":"Deep eutectic solvent mediated synthesis of 3,4-dihydropyrimidin-2(1H)-ones and evaluation of biological activities targeting neurodegenerative disorders","volume":"118","author":"Saleem Khan","year":"2022","journal-title":"Bioorg Chem"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130327_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24122306","article-title":"Synthesis, crystal structure, and biological evaluation of fused thiazolo[3,2-a]pyrimidines as new acetylcholinesterase inhibitors","volume":"24","author":"Mahgoub","year":"2019","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130327_bb0100","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1080\/10406638.2021.1933102","article-title":"Design, green synthesis, and biological evaluation of new substituted Tetrahydropyrimidine derivatives as acetylcholinesterase inhibitors","volume":"42","author":"Mariki","year":"2022","journal-title":"Polycycl Aromat Compd"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130327_bb0105","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1021\/acschemneuro.9b00430","article-title":"Novel molecular hybrids of N-benzylpiperidine and 1,3,4-oxadiazole as multitargeted therapeutics to treat Alzheimer\u2019s disease","volume":"10","author":"Sharma","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmcl.2025.130327_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111707","article-title":"Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer\u2019s disease","volume":"183","author":"Tripathi","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130327_bb0115","first-page":"907","article-title":"Novel 1,2,4-oxadiazole derivatives as selective butyrylcholinesterase inhibitors: design, synthesis, and biological evaluation","volume":"20","author":"Nazari","year":"2021","journal-title":"EXCLI J"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130327_bb0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jhet.4756","article-title":"Cobalt perchlorate hexahydrate catalyzed one-pot synthesis of dihydropyrimidin-ones\/\u2212thiones through sonochemistry and its mechanistic study using density functional theory calculations","volume":"61","author":"Ambatwar","year":"2024","journal-title":"J Heterocyclic Chem"},{"issue":"8","key":"10.1016\/j.bmcl.2025.130327_bb0125","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2174\/1570193X20666230601093704","article-title":"Biginelli reaction: a multi-component type of reaction and synthetic advancement in the synthesis of bioactive dihydropyrimidinone derivatives","volume":"21","author":"Ambatwar","year":"2024","journal-title":"Mini Rev Org Chem"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130327_bb0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol"},{"issue":"17","key":"10.1016\/j.bmcl.2025.130327_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127370","article-title":"Discovery of biphenyl pyrazole scaffold for neurodegenerative diseases: a novel class of acetylcholinesterase-centered multitargeted ligands","volume":"30","author":"Gabr","year":"2020","journal-title":"Bioorg Med Chem Lett."},{"issue":"June","key":"10.1016\/j.bmcl.2025.130327_bb0140","first-page":"1","article-title":"Structure-based virtual screening methods for the identification of novel phytochemical inhibitors targeting furin protease for the management of COVID-19","volume":"14","author":"Kumar Tiwari","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130327_bb0145","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1080\/07391102.2023.2208214","article-title":"Inhibition of Mycobacterium tuberculosis resuscitation-promoting factor B (RpfB) by microbially derived natural compounds: a computational study","volume":"42","author":"Chouhan","year":"2024","journal-title":"J Biomol Struct Dyn"},{"issue":"June 2024","key":"10.1016\/j.bmcl.2025.130327_bb0150","article-title":"Discovery of novel hybrid tryptamine-rivastigmine molecules as potent AChE and BChE inhibitors exhibiting multifunctional properties for the management of Alzheimer\u2019s disease","volume":"283","author":"Shankar","year":"2025","journal-title":"Eur J Med Chem"},{"issue":"February","key":"10.1016\/j.bmcl.2025.130327_bb0155","article-title":"Discovery of novel substituted (Z)-N\u2032-hydroxy-3-(3-phenylureido)benzimidamide derivatives as multifunctional molecules targeting pathological hallmarks of Alzheimer\u2019s disease","volume":"280","author":"Shankar","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"20","key":"10.1016\/j.bmcl.2025.130327_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127477","article-title":"New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation","volume":"30","author":"Singh","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130327_bb0165","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijbiomac.2022.05.009","article-title":"Crystal structure of human acetylcholinesterase in complex with tacrine: implications for drug discovery","volume":"210","author":"Dileep","year":"2022","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130327_bb0170","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1021\/acs.jafc.1c06110","article-title":"Integration of molecular docking analysis and molecular dynamics simulations for studying food proteins and bioactive peptides","volume":"70","author":"Vidal-Limon","year":"2022","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.bmcl.2025.130327_bb0175","first-page":"1","article-title":"Networkodynamic approach to perceive the key phytoconstituents of E. officinalis (Amla) as natural BACE1 inhibitors: an in-silico study","author":"Agarwal","year":"2024","journal-title":"J Biomol Struct Dyn"},{"issue":"22","key":"10.1016\/j.bmcl.2025.130327_bb0180","doi-asserted-by":"crossref","first-page":"12643","DOI":"10.1080\/07391102.2023.2167122","article-title":"Cytosporone E analogues as BRD4 inhibitors for cancer treatment: molecular docking and molecular dynamic investigations","volume":"41","author":"Makki","year":"2023","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130327_bb0185","doi-asserted-by":"crossref","DOI":"10.1007\/s11011-024-01460-2","article-title":"Integrated systems pharmacology, molecular docking, and MD simulations investigation elucidating the therapeutic mechanisms of BHD in Alzheimer\u2019s disease treatment","volume":"40","author":"Chowdhury","year":"2025","journal-title":"Metab Brain Dis"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25002367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25002367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:20:54Z","timestamp":1776918054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25002367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":37,"alternative-id":["S0960894X25002367"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130327","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of novel dihydropyrimidine\u2013oxadiazole hybrid scaffolds as anticholinesterase agents: SAR and in-silico studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130327"}}